TFCP2, transcription factor CP2, 7024

N. diseases: 46; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of colon and/or rectum
0.020 AlteredExpression disease BEFREE LSF expression and its prognostic implication in colorectal cancer. 25337247 2014
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 Biomarker phenotype BEFREE Microarray studies revealed that as a transcription factor, LSF modulated specific genes regulating invasion, angiogenesis, chemoresistance, and senescence. 20404171 2010
Human immunodeficiency virus (HIV) II infection category B1
0.020 Biomarker disease BEFREE Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter. 15857981 2005
CUI: C0494463
Disease: Alzheimer Disease, Late Onset
Alzheimer Disease, Late Onset
0.020 GeneticVariation disease BEFREE Association of the 3' UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. 12555245 2003
Human immunodeficiency virus (HIV) II infection category B1
0.020 Biomarker disease BEFREE The host factor LSF represses the human immunodeficiency virus type 1 long terminal repeat (LTR) by mediating recruitment of histone deacetylase. 12414976 2002
CUI: C0494463
Disease: Alzheimer Disease, Late Onset
Alzheimer Disease, Late Onset
0.020 GeneticVariation disease BEFREE We found different LBP-1c/CP2/LSF allele distributions in our AD cases and controls (p=0.048); the A allele was associated with reduced AD risk. 11283204 2001
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE Recently, we reported that the protumourigenic roles of YAP in liver cancer are indispensable for transcription factor CP2 (TFCP2) in a Hippo-independent manner; however, proteins that act upstream to simultaneously control YAP and TFCP2 remain unclear. 31501420 2019
CUI: C0240602
Disease: opioid use
opioid use
0.010 Biomarker disease BEFREE Patients with degenerative hip and lumbar spine pathology that undergo THA prior to LSF have a significantly increased risk of postoperative dislocation, infection, revision surgery, and prolonged opioid use compared to THA after LSF. 31809465 2019
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 Biomarker disease BEFREE Recently, we reported that the protumourigenic roles of YAP in liver cancer are indispensable for transcription factor CP2 (TFCP2) in a Hippo-independent manner; however, proteins that act upstream to simultaneously control YAP and TFCP2 remain unclear. 31501420 2019
Squamous cell carcinoma of esophagus
0.010 AlteredExpression disease BEFREE High expression of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues suggests promoting ESCC progression and poor prognosis, co-expression of MAGE-A11 and transcription factors even worse. 31126819 2019
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 Biomarker disease BEFREE Recently, we reported that the protumourigenic roles of YAP in liver cancer are indispensable for transcription factor CP2 (TFCP2) in a Hippo-independent manner; however, proteins that act upstream to simultaneously control YAP and TFCP2 remain unclear. 31501420 2019
Secondary malignant neoplasm of liver
0.010 Biomarker disease BEFREE To evaluate the feasibility of a same-day yttrium-90 (<sup>90</sup>Y) radioembolization protocol with resin microspheres (including pretreatment angiography, lung shunt fraction [LSF] determination, and radioembolization) for the treatment of hepatocellular carcinoma (HCC) and liver metastases. 30819470 2019
CUI: C1266134
Disease: Spindle cell rhabdomyosarcoma
Spindle cell rhabdomyosarcoma
0.010 GeneticVariation disease BEFREE The final diagnosis was spindle cell rhabdomyosarcoma of a lumbar vertebra with a FUS-TFCP2 fusion. 30948206 2019
CUI: C1384494
Disease: Metastatic Carcinoma
Metastatic Carcinoma
0.010 Biomarker group BEFREE A spindle cell rhabdomyosarcoma with a FUS-TFCP2 fusion in a vertebral bone is rare and should be differentiated from metastatic carcinoma, particularly in the elderly. 30948206 2019
CUI: C4722419
Disease: Extrapulmonary Small Cell Carcinoma
Extrapulmonary Small Cell Carcinoma
0.010 AlteredExpression disease BEFREE Expression and prognostic significance of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues. 31126819 2019
CUI: C0220611
Disease: Childhood Rhabdomyosarcoma
Childhood Rhabdomyosarcoma
0.010 GeneticVariation disease BEFREE Spindle cell rhabdomyosarcomas carrying the FUS-TFCP2 fusion are very rare rhabdomyosarcoma variants with osseous predilection. 29758589 2018
CUI: C0279550
Disease: Adult Rhabdomyosarcoma
Adult Rhabdomyosarcoma
0.010 GeneticVariation disease BEFREE Spindle cell rhabdomyosarcomas carrying the FUS-TFCP2 fusion are very rare rhabdomyosarcoma variants with osseous predilection. 29758589 2018
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 AlteredExpression disease BEFREE We report that suppressed TFCP2 expression and elevated ASIC2a expression were associated with glucose hypometabolism in the hippocampi of humans with epilepsy and of rat epilepsy model brains. 28725010 2017
CUI: C0030193
Disease: Pain
Pain
0.010 AlteredExpression phenotype BEFREE Despite the subjective pain sensation being unaltered, the two anodal (real) interventions significantly decreased OP activity associated with pain-SEFs. 28719422 2017
CUI: C0036572
Disease: Seizures
Seizures
0.010 AlteredExpression phenotype BEFREE Our findings suggest that hippocampal glucose hypometabolism elevates ASIC2a expression by suppressing TFCP2 expression, which further enhances the intrinsic excitability of CA1 pyramidal neurons and increases seizure susceptibility in patients with temporal lobe epilepsy. 28725010 2017
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.010 AlteredExpression disease BEFREE We have shown that the transcription factor TFCP2 was up-regulated in the pancreatic cancer. 29050300 2017
CUI: C0239589
Disease: Pain in finger
Pain in finger
0.010 Biomarker phenotype BEFREE Somatosensory-evoked magnetic fields following noxious intraepidermal electrical stimulation to the left index finger (pain-SEFs) were recorded before and after tDCS with a single-blind, sham-controlled, cross-over trial design. 28719422 2017
CUI: C0341439
Disease: Chronic liver disease
Chronic liver disease
0.010 Biomarker group BEFREE Here, we genotyped 7 SNPs of TFCP2 in a case-control study of 119 patients with HCC and 200 patients with chronic liver disease. 28348581 2017
CUI: C0346647
Disease: Malignant neoplasm of pancreas
Malignant neoplasm of pancreas
0.010 AlteredExpression disease BEFREE We have shown that the transcription factor TFCP2 was up-regulated in the pancreatic cancer. 29050300 2017
CUI: C0025202
Disease: melanoma
melanoma
0.010 Biomarker disease BEFREE Transcription factor LSF (TFCP2) inhibits melanoma growth. 26506241 2016